US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID
https://ift.tt/eA8V8J
Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...
from NDTV News - World-news https://ift.tt/3hX2lsF
Latest
No comments:
Post a Comment
Please Don't Send any Spam Link in Comments